These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2112882)

  • 1. Recombinant human alpha-interferon therapy for chronic non-A, non-B hepatitis: second report.
    Kakumu S; Arao M; Yoshioka K; Hayashi H; Kusakabe A; Hirofuji H; Kawabe M
    Am J Gastroenterol; 1990 Jun; 85(6):655-9. PubMed ID: 2112882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of posttransfusion non-A, non-B acute and chronic hepatitis with human fibroblast beta-interferon: a preliminary report.
    Ohnishi K; Nomura F; Iida S
    Am J Gastroenterol; 1989 Jun; 84(6):596-600. PubMed ID: 2499184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of chronic non-A,non-B hepatitis with recombinant human alpha interferon. A preliminary report.
    Hoofnagle JH; Mullen KD; Jones DB; Rustgi V; Di Bisceglie A; Peters M; Waggoner JG; Park Y; Jones EA
    N Engl J Med; 1986 Dec; 315(25):1575-8. PubMed ID: 3097544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study of the relapse of patients with chronic hepatitis B undergoing first and repeated recombinant interferon-alpha therapy during long-term follow up].
    Liu DL; Luo KX; Feng XR; Fu QX; Hou JL
    Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(26):1840-3. PubMed ID: 17922996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant human alpha-interferon in patients with chronic non-A, non-B hepatitis: a multicenter randomized controlled trial from France.
    Marcellin P; Boyer N; Giostra E; Degott C; Courouce AM; Degos F; Coppere H; Cales P; Couzigou P; Benhamou JP
    Hepatology; 1991 Mar; 13(3):393-7. PubMed ID: 1900254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pilot study of a short course of ribavirin and alpha interferon in the treatment of chronic active hepatitis C not responding to alpha-interferon alone.
    Scotto G; Fazio V; Tantimonaco G
    Ital J Gastroenterol; 1996 Dec; 28(9):505-11. PubMed ID: 9131395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Interferon alpha-2a treatment of 26 patients with chronic non-A non-B hepatitis. Predictive factors of response].
    Lunel-Fabiani F; Guivarch P; Valla D; Grippon P; Marques MA; Huraux JM; Le Charpentier Y; Levy VG; Bousquet O; Opolon P
    Gastroenterol Clin Biol; 1990; 14(10):705-9. PubMed ID: 2124569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant interferon-alpha and ursodeoxycholic acid versus interferon-alpha alone in the treatment of chronic hepatitis C: a randomized clinical trial with long-term follow-up.
    Angelico M; Gandin C; Pescarmona E; Rapicetta M; Del Vecchio C; Bini A; Spada E; Baroni CD; Capocaccia L
    Am J Gastroenterol; 1995 Feb; 90(2):263-9. PubMed ID: 7847298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recombinant alfa interferon in the treatment of chronic B and non-A, non-B hepatitis: preliminary results].
    da Silva LC; Carrilho FJ; da Fonseca LE; Farias SM; Faggion P; Granato CF; Vianna MR; Alves VA; Gayotto LC
    Rev Hosp Clin Fac Med Sao Paulo; 1989; 44(5):201-6. PubMed ID: 2517713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial.
    Di Bisceglie AM; Martin P; Kassianides C; Lisker-Melman M; Murray L; Waggoner J; Goodman Z; Banks SM; Hoofnagle JH
    N Engl J Med; 1989 Nov; 321(22):1506-10. PubMed ID: 2509917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphoblastoid alpha-interferon for chronic hepatitis C: a randomized controlled study.
    Castilla A; Camps-Bansell J; Civeira MP; Prieto J
    Am J Gastroenterol; 1993 Feb; 88(2):233-9. PubMed ID: 8424427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of human leucocyte alpha-interferon treatment for chronic hepatitis C virus infection.
    Weiland O; Chen M; Lindh G; Mattsson L; Schvarcz R; Sönnerborg A; Wahl M; Wejstål R; Widell A; Norkrans G
    Scand J Infect Dis; 1995; 27(5):319-24. PubMed ID: 8588128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Amantadine-HCL in the treatment of chronic hepatitis C in non-responders to alpha-interferon. Effect on ALT serum levels and viral load].
    Parolin MB; Lacerda MA; Lopes RW
    Arq Gastroenterol; 1999; 36(2):63-7. PubMed ID: 10511883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of daily administration period of natural alpha-interferon in patients with chronic hepatitis C.
    Toyoda H; Nakano S; Kumada T; Takeda I; Sugiyama K; Osada T; Kiriyama S
    Am J Gastroenterol; 1996 Apr; 91(4):743-7. PubMed ID: 8677941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long-term treatment of cryptogenic hepatitis C using recombinant interferon alpha].
    Hopf U; Möller B; König V; Küther S; Lobeck H; Huhn D
    Z Gastroenterol; 1990 Sep; 28(9):453-7. PubMed ID: 2125776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B.
    Musch E; Högemann B; Gerritzen A; Fischer HP; Wiese M; Kruis W; Malek M; Gugler R; Schmidt G; Huchzermeyer H; Gerlach U; Dengler HJ; Sauerbruch T
    Hepatogastroenterology; 1998; 45(24):2282-94. PubMed ID: 9951911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of chronic hepatitis C with interferon-alpha. Clinical histological and virological implications.
    Olaso V; Córdoba J; Berenguer M; Prieto M; Lainez B; Argüello L; Valverde J; Pascual S; Gobernado M; Berenguer J
    Rev Esp Enferm Dig; 1997 Jul; 89(7):531-50. PubMed ID: 9265839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of chronic hepatitis C with interferon alpha: long-term follow-up and prognostic relevance of HCV genotypes.
    Hopf U; Berg T; König V; Küther S; Heuft HG; Lobeck H
    J Hepatol; 1996; 24(2 Suppl):67-73. PubMed ID: 8836892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of long term recombinant interferon-alfa in patients with chronic hepatitis C. A clinical, biological, histological and immunohistological study.
    Poynard T; Bedossa P; Mathurin P; Naveau S; Delfraissy JF; Lemaigre G; Chaput JC
    Gastroenterol Clin Biol; 1991; 15(8-9):615-9. PubMed ID: 1752373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of interferon alfa and ribavirin combination therapy in naive patients with chronic hepatitis C.
    Chemello L; Cavalletto L; Bernardinello E; Guido M; Pontisso P; Alberti A
    J Hepatol; 1995; 23 Suppl 2():8-12. PubMed ID: 8720287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.